This story originally appeared in sister publication The Recorder.
SAN FRANCISCO — After landing a preliminary injunction in a patent suit, blood glucose testing company LifeScan Inc. took an "impermissible shortcut" by using confidential information turned over in litigation to notify the defendants' distributors, U.S. District Judge William Orrick III ruled Wednesday.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
